AI-cloud partnerships transform drug discovery pipelines

The pharmaceutical industry faces pressure to accelerate drug discovery while managing computational complexity. Traditional methods struggle to process millions of molecular candidates, delaying development timelines.

This webinar explores how generative AI transforms drug discovery through AWS, Nvidia, and Rescale partnerships. Topics include:

• Nvidia's BioNemo for molecular generation and protein folding
• AWS Health Omics for serverless bioinformatics workflows
• Rescale's HPC-as-a-service for seamless cloud model deployment
• Real-world applications cutting timelines from months to weeks

Discover how AI-driven approaches accelerate therapeutic development.